Proteo focuses on the development of therapeutic solutions based on the body's own protective tools and weapons for diseases with significant unmet needs.

The company develops Elafin for the prevention of life-threatening complications in highly invasive major surgery and the treatment of life-threatening diseases like pulmonary arterial hypertension.

News

2019-03-28

Proteo’s Elafin Enters The Clinic For Subcutaneous Use In Pulmonary Arterial Hypertension




PROTEO BIOTECH AG
Am Kiel-Kanal 44
24106 Kiel
Germany
phone: +49 431 8888462
https://proteo.de/pages/ – printed on 2020-10-22 22:43:42